Hypor Lands in Viet Nam
VIET NAM - Hypor, the pig breeding division of Hendrix Genetics, announced today that their first delivery of GGPs/GPs to Viet Nam arrived on 30 August.
22 September 2009
3 minute read
Japfa Comfeed Vietnam Ltd, a division of well established and successful agriculture integrator PT Japfa Comfeed Indonesia Tbk, accepted delivery of the Canadian produced breeding stock for their new pork production business venture.
The arrival of the Hypor genetics highlights the commitment of Japfa Comfeed Vietnam Ltd. to develop a supply of quality pork products for the growing local market.
Raf Beeren, Deputy Managing Director Hypor sees the introduction of Hypor Genetics into the Vietnamese market as a natural progression of market share growth in Asia. "Building on our experiences in Japan, The Philippines, South Korea, Thailand and China, we have a long history for developing partnerships with successful integrators in this region and Japfa Comfeed has an equally distinguished record in animal feed manufacturing, chicken breeding, poultry processing and aquaculture farming throughout the region," said Beeren.
Viet Nam’s agriculture sector and specifically its pork production targets are most ambitious with analysts predicting more than a 40 per cent increase in production in the next 3 three years. The country currently has the world’s fourth largest sow population. Acknowledged success in Asian markets and its unique BioHypor closed herd breeding program were key factors in Japfa Comfeed’s decision to purchase Hypor high health genetics for the initial phase of their integration project.
Dr. Kuswanto, Senior Vice President, Japfa Comfeed Vietnam Ltd. sees unlimited opportunities for both Hypor and Japfa in this market. He is targeting one million tons of annual feed production for the project by 2015. "Given the performance of Hypor genetics, their BioHypor breeding program and their technical support team and our track record as an efficient, high quality, low cost organization we can meet this ambitious goal," said Dr. Kuswanto.
